Figure 5 . Treatment with recombinant murine CXCL16 enhanced inflammatory response in CLP-induced nonsevere sepsis. (A) Numbers of leukocytes including neutrophils, monocytes/macrophages and lymphocytes in peritoneal lavage fluid (PLF) of septic mice treated with or without recombinant murine CXCL16 (0.5 μg/injection). (B) Cytokine and chemokine levels in PLF and blood from septic mice (n = 5) treated with or without recombinant murine CXCL16 (0.5 μg/injection) at 24 h after nonsevere CLP. p <0.05, p <0.01,p <0.001 when compared with septic mice treated with PBS control (Mann-Whitney U test).